LifeMD, Inc. Announces Cash Dividend for Series A Preferred Stock Holders
LifeMD, Inc. Announces Cash Dividend for Series A Preferred Stock Holders
The dividend will be paid on January 15, 2025, to holders of record at close of business on January 3, 2025.LifeMD authorized a cash dividend of $0.5546875 per share for its Series A Preferred Stock, payable January 15, 2025.
LifeMD授权每股现金分红为0.5546875美元，适用于其A系列优先股，支付日期为2025年1月15日。
Quiver AI Summary
Quiver AI 概要
LifeMD, Inc. has announced a cash dividend of $0.5546875 per share for holders of its 8.875% Series A Cumulative Perpetual Preferred Stock, which will be paid on January 15, 2025, to shareholders recorded by the end of January 3, 2025. LifeMD is a provider of virtual primary care services, offering telemedicine, lab and pharmacy access, and specialized treatments for over 200 conditions through a robust digital care platform and a large affiliated medical group. The announcement also includes cautionary notes about forward-looking statements, emphasizing that actual results may vary due to various risks and uncertainties.
LifeMD公司宣布将向其8.875%系列A累积永久优先股的持有者支付每股0.5546875美元的现金分红，该分红将在2025年1月15日支付，支付对象为截至2025年1月3日的股东。LifeMD是一家提供虚拟初级医疗服务的公司，利用强大的数字护理平台和大型附属医疗集团，为超过200种控件提供远程医疗、实验室和药房访问以及专业治疗。该公告还包含对前瞻性声明的警示，强调实际结果可能因各种风险和不确定性而有所不同。
Potential Positives
潜在的积极因素
- The announcement of a cash dividend signals strong financial health and a commitment to returning value to shareholders.
- The dividend payment date and record date provide clear communication for investors, promoting trust and transparency.
- LifeMD's positioning as a leading provider of virtual primary care services may enhance investor confidence in its growth potential and sustainable business model.
- 现金分红的公告标志着强健的财务状况以及对股东回报价值的承诺。
- 分红支付日期和记录日期为投资者提供了清晰的沟通，促进了Trust和透明度。
- 作为虚拟初级医疗服务的领先提供商，LifeMD的定位可能增强投资者对其增长潜力和可持续业务模式的信心。
Potential Negatives
潜在负面因素
- The announcement of a cash dividend may signal financial pressures or liquidity concerns, as companies typically only issue dividends when they have sufficient cash flow and profitability.
- The emphasis on forward-looking statements and associated risks may raise concerns among investors about the company's future performance and its ability to meet its projections, particularly given market uncertainties.
- The press release includes a cautionary note about risks and uncertainties that could materially affect actual results, which may create apprehension regarding the stability or growth prospects of the company.
- 现金分红的公告可能表明财务压力或流动性问题，因为公司通常只有在拥有足够的现金流和盈利能力时才会发放分红。
- 对未来展望声明及相关风险的强调可能会引发投资者对公司未来表现和达成预测能力的担忧，尤其是考虑到市场的不确定性。
- 新闻稿中包含一条关于可能对实际结果产生重大影响的风险和不确定性的警告，这可能会引起对公司稳定性或增长前景的忧虑。
FAQ
常见问题
What is the dividend amount announced by LifeMD?
LifeMD公告的分红金额是多少？
LifeMD has announced a cash dividend of $0.5546875 per share for its 8.875% Series A Preferred Stock.
LifeMD宣布其8.875% A系列优先股的现金分红为每股0.5546875美元。
When will the dividend be paid by LifeMD?
LifeMD将于何时支付分红？
The dividend will be paid on January 15, 2025, to holders of record at close of business on January 3, 2025.
分红将于2025年1月15日支付，支付给在2025年1月3日营业结束时的登记持有人。
What services does LifeMD provide?
LifeMD提供什么服务？
LifeMD provides virtual primary care, including telemedicine, laboratory access, pharmacy services, and specialized treatment for over 200 conditions.
LifeMD提供虚拟基础医疗，包括远程医疗、实验室访问、药房服务以及针对200多种疾病的专门治疗。
How can I learn more about LifeMD?
我如何能了解更多关于LifeMD的信息？
For more information about LifeMD and its offerings, visit their website at LifeMD.com.
欲了解更多关于LifeMD及其产品的信息，请访问他们的网站LifeMD.com。
What should investors know about forward-looking statements?
投资者应该了解关于前瞻性声明的哪些信息？
Forward-looking statements involve risks and uncertainties that may cause actual results to differ from current expectations. Refer to SEC filings for details.
前瞻性声明涉及的风险和不确定性可能导致实际结果与当前预期有所不同。有关详细信息，请参阅SEC文件。
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
免责声明：这是由GlobeNewswire分发的新闻稿的人工智能生成摘要。用于总结这份稿件的模型可能会出错。请在这里查看完整发布。
$LFMD Insider Trading Activity
$LFMD内部交易活动
$LFMD insiders have traded $LFMD stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
$LFMD的内部人士在过去6个月内在公开市场上交易了$LFMD股票2次。其中，有1次为购买，1次为出售。
Here's a breakdown of recent trading of $LFMD stock by insiders over the last 6 months:
以下是过去6个月内部人士对$LFMD股票的最新交易情况：
- JUSTIN SCHREIBER (Chief Executive Officer) sold 25,000 shares.
- STEFAN GALLUPPI (Chief Innovation Officer) purchased 3,000 shares.
- JUSTIN SCHREIBER（首席执行官）出售了25,000股。
- STEFAN GALLUPPI（首席创新官）购买了3,000股。
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
要跟踪内部交易，请查看Quiver Quantitative的内部交易特斯拉-仪表。
$LFMD Hedge Fund Activity
$LFMD对冲基金活动
We have seen 53 institutional investors add shares of $LFMD stock to their portfolio, and 72 decrease their positions in their most recent quarter.
我们看到53家机构投资者在最近的一个季度中增持了$LFMD股票，72家减少了其持仓。
Here are some of the largest recent moves:
以下是最近的一些重大变动：
- AQR CAPITAL MANAGEMENT LLC added 687,280 shares (+inf%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC added 664,329 shares (+719.5%) to their portfolio in Q3 2024
- EAM INVESTORS, LLC removed 411,610 shares (-100.0%) from their portfolio in Q2 2024
- CUBIST SYSTEMATIC STRATEGIES, LLC removed 347,455 shares (-63.0%) from their portfolio in Q3 2024
- G2 INVESTMENT PARTNERS MANAGEMENT LLC removed 305,000 shares (-100.0%) from their portfolio in Q3 2024
- MORGAN STANLEY removed 287,843 shares (-45.9%) from their portfolio in Q3 2024
- LAURION CAPITAL MANAGEMENT LP removed 285,637 shares (-100.0%) from their portfolio in Q2 2024
- AQR CAPITAL MANAGEMENT LLC 在2024年第三季度增加了687,280股(+inf%)到他们的投资组合中
- MILLENNIUM MANAGEMENT LLC 在2024年第三季度增加了664,329股(+719.5%)到他们的投资组合中
- EAM INVESTORS, LLC 在2024年第二季度移除了411,610股(-100.0%)
- CUBIST SYSTEMATIC STRATEGIES, LLC 在2024年第三季度移除了347,455股(-63.0%)
- G2 INVESTMENT PARTNERS MANAGEMENT LLC 在2024年第三季度移除了305,000股(-100.0%)
- 摩根士丹利 在2024年第三季度移除了287,843股(-45.9%)
- LAURION CAPITAL MANAGEMENT LP 在2024年第二季度移除了285,637股(-100.0%)
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要跟踪对冲基金的股票投资组合，请查看Quiver Quantitative的机构持有情况仪表。
Full Release
完整发布
NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) --
LifeMD, Inc.
(Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
纽约，2024年12月24日（环球新闻通讯） --
LifeMD, Inc.
（纳斯达克：LFMD），一家领先的虚拟初级医疗服务提供商，今天宣布其董事会已授权向公司8.875%系列A累积永久优先股（纳斯达克：LFMDP）的持有者支付现金分红，每股为0.5546875美元。
The preferred dividend will be paid on January 15, 2025, to holders of record at the close of business on January 3, 2025.
优先股息将于2025年1月15日支付给截至2025年1月3日营业结束时登记的持有人。
About LifeMD, Inc.
关于LifeMD公司。
LifeMD
is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit
LifeMD.com
.
LifeMD
是一家领先的虚拟初级医疗服务提供商。LifeMD提供远程医疗、实验室和药房服务的获取，以及针对超过200种疾病的专业治疗，包括初级医疗、男性和女性健康、体重管理和激素治疗。公司利用一个垂直整合的专有数字护理平台、一个覆盖50个州的医务组、一个22,500平方英尺的附属药房以及一个美国的患者护理中心，以增加对高质量和可负担得起的护理的获取。有关更多信息，请访问
LifeMD.com
.
Cautionary Note Regarding Forward Looking Statements
关于前瞻性声明的警示说明
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: "believe," "expect," "anticipate," "project," "should," "plan," "will," "may," "intend," "estimate," "predict," "continue," and "potential," or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: "believe," "expect," "anticipate," "project," "should," "plan," "will," "may," "intend," "estimate," "predict," "continue," and "potential," or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.
Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, "Risk Factors" identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.
Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, "Risk Factors" identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-k, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.
新闻稿中做出的任何前瞻性声明均基于在发布之日我们当前掌握的信息。我们无需承担更新或修订任何前瞻性声明的义务，无论是由于新信息、未来事件或其他原因，除非适用法律或法规要求。
Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com
投资者联系
马克·本尼森，首席财务官
marc@lifemd.com
Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com
媒体联系
杰西卡·弗里德曼，首席营销官
press@lifemd.com
